Bulletin Updates
Anupam Rasayan's Rs 829-crore open offer: Draft letter filed for Bliss GVS Pharma – 10 Jun 2026
Jun 10, 2026
The DLO is now with SEBI: Rs 299 a share in cash for 26% of the pharma maker, unconditional and with no minimum acceptance. The Surat specialty chemicals firm's boldest diversification move is formally in motion.
The full story is for subscribers. Log in to read it, or start a free trial.
Log in Start a free trial »
Log in Start a free trial »